Minerva Neurosciences Inc

Last updated September 27, 2026

Organization details

Legal name
Minerva Neurosciences Inc
Ownership
Public
Status
Active
Headquarters country
United States
Ticker symbol
NERV
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001598646

Board of directors

Chief executives

Dates unknown

Board connections

2 of this board's directors also sit on 3 other boards.

Network of Minerva Neurosciences Inc's board connections Gain Therapeutics Inc. Gain Therapeutics Inc. NovoCure Limited NovoCure Limited SI-BONE Inc. SI-BONE Inc. Hans Peter Hasler Hans Peter Hasler Jeryl L. Hilleman Jeryl L. Hilleman Minerva Neurosciences Inc
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$0
0 sales by 0 insiders
Date Insider Transaction Shares Price Value
May 2, 2023 Remy Luthringer Director, Officer (CEO) Open-market sale −3,641 $3.76 $13,690
May 1, 2023 Remy Luthringer Director, Officer (CEO) Open-market sale −23,753 $3.85 $91,449
May 1, 2023 Race Geoff Officer (President) Open-market sale −22,082 $3.85 $85,016
May 1, 2023 Ahlholm Frederick W Officer (SVP, CFO and Secretary) Open-market sale −3,580 $4.48 $16,038
Apr 28, 2023 Remy Luthringer Director, Officer (CEO) Grant or award +88,077 — —
Apr 28, 2023 Race Geoff Officer (President) Grant or award +46,987 — —
Apr 28, 2023 Ahlholm Frederick W Officer (SVP, CFO and Secretary) Grant or award +19,843 — —

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.